Company Filing History:
1 out of 8 
1 out of 8 Years Active: 2004-2007
Title: Thomas Scholzen: Innovator in Biopharmaceuticals
Introduction
Thomas Scholzen is a notable inventor based in Neritz, Germany. He has made significant contributions to the field of biopharmaceuticals, particularly through his innovative patents. With a total of 2 patents, Scholzen's work focuses on the development of compounds and antibodies that have potential applications in medical treatments.
Latest Patents
Scholzen's latest patents include groundbreaking inventions. One patent is titled "Transfer compounds, production and use thereof." This invention relates to the use of a carboxy-terminal fragment of the Ki-67 protein as a compound for intracellular transfer and release by cells. It also encompasses transfer compounds containing the Ki-67 protein and the vectors encoding them. Additionally, the invention discusses pharmaceutical compositions that utilize the transfer protein as an excipient or active agent in treating diseases.
Another significant patent is "Monoclonal antibodies against human protein Mcm3, process for their production, and their use." This invention focuses on monoclonal antibodies against the human Mcm3 protein, including hybridoma cell lines that produce these antibodies. The patent outlines procedures for their production and their use in pharmaceutical compositions for preventing and treating diseases associated with Mcm3 expression. The monoclonal antibodies are designed to detect and bind human Mcm3 specifically in various detection systems.
Career Highlights
Throughout his career, Thomas Scholzen has worked with several prominent companies in the biopharmaceutical sector. Notable organizations include Dakocytomation Denmark A/S and Faustus Forschungs Cie, as well as Translational Cancer Research GmbH. His experience in these companies has contributed to his expertise and innovative capabilities in the field.
Collaborations
Scholzen has collaborated with several professionals in his field, including Johannes Gerdes and Claudia Wohlenberg. These collaborations have likely enhanced his research and development efforts, leading to his successful patent applications.
Conclusion
Thomas Scholzen is a distinguished inventor whose work in biopharmaceuticals has led to significant advancements in medical treatments. His innovative patents reflect his dedication to improving healthcare through scientific research and development.